Skip to the page

Data / Form D filings / BioPhoundry, Inc.

BioPhoundry, Inc.: Form D filing

BioPhoundry, Inc., a biotechnology company in Chapel Hill, NC, filed a Form D with the SEC in 2025. The latest, on January 29, 2025, reports $1.1 million sold of a $1.2 million offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1521 E FRANKLIN ST, C212, Chapel Hill, NC, 27514
Phone
(571) 437-6236
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2050545

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jan 29, 2025New notice$1,244,100$1,145,098$99,0027Dec 10, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Louis T. MarlowDirector
Sahan B.W. LiyanagederaExecutive Officer, Director
Rani T. BrooksExecutive Officer, Director

Other biotechnology companies in North Carolina that filed recently

Every Form D from the week of Jan 27, 2025 · All recent filings in North Carolina · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what BioPhoundry, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.